Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 1/2016

01-01-2016 | Image of the Month

Intense PSMA-expression using 68Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis

Authors: Christoph Rischpler, Tobias Maurer, Markus Schwaiger, Matthias Eiber

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2016

Login to get access

Excerpt

The prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer (PC) cells. The recently introduced PSMA-PET/CT has evolved as a powerful imaging tool for staging of PC [13]. Albeit the high specificity of PSMA-tracers, there are reports of high PSMA-expression in non-prostatic malignant (e.g., renal cell carcinoma, bronchial carcinoma, and glioblastoma) and benign (schwannomas) lesions [4]. These reports raise concerns over the specificity of PSMA-PET imaging indicating the need for thorough review of accompanying morphological images besides exclusive interpretation of and reliance on PSMA-expression in PET. …
Literature
1.
go back to reference Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of Hybrid (6)(8)Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy. J Nucl Med. 2015;56:668–74.CrossRefPubMed Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of Hybrid (6)(8)Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy. J Nucl Med. 2015;56:668–74.CrossRefPubMed
2.
go back to reference Afshar-Oromieh A, Avtzi E, Giesel FL, Holland-Letz T, Linhart HG, Eder M, et al. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42:197–209.PubMedCentralCrossRefPubMed Afshar-Oromieh A, Avtzi E, Giesel FL, Holland-Letz T, Linhart HG, Eder M, et al. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42:197–209.PubMedCentralCrossRefPubMed
3.
go back to reference Maurer T, Beer AJ, Wester HJ, Kubler H, Schwaiger M, Eiber M. Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: promising novel option in prostate cancer imaging? Int J Urol. 2014;21:1286–8.CrossRefPubMed Maurer T, Beer AJ, Wester HJ, Kubler H, Schwaiger M, Eiber M. Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: promising novel option in prostate cancer imaging? Int J Urol. 2014;21:1286–8.CrossRefPubMed
4.
go back to reference Wang W, Tavora F, Sharma R, Eisenberger M, Netto GJ. PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma. Urol Oncol. 2009;27:525–8.CrossRefPubMed Wang W, Tavora F, Sharma R, Eisenberger M, Netto GJ. PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma. Urol Oncol. 2009;27:525–8.CrossRefPubMed
5.
go back to reference Wu JS, Hochman MG. Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology. 2009;253:297–316.CrossRefPubMed Wu JS, Hochman MG. Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology. 2009;253:297–316.CrossRefPubMed
Metadata
Title
Intense PSMA-expression using 68Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis
Authors
Christoph Rischpler
Tobias Maurer
Markus Schwaiger
Matthias Eiber
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-3235-y

Other articles of this Issue 1/2016

European Journal of Nuclear Medicine and Molecular Imaging 1/2016 Go to the issue